These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24608432)

  • 21. Primate-specific miRNA-637 inhibited tumorigenesis in human pancreatic ductal adenocarcinoma cells by suppressing Akt1 expression.
    Xu RL; He W; Tang J; Guo W; Zhuang P; Wang CQ; Fu WM; Zhang JF
    Exp Cell Res; 2018 Feb; 363(2):310-314. PubMed ID: 29366808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
    Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
    Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
    Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z
    Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA negative regulator of antiviral response contributes to pancreatic ductal adenocarcinoma progression
    Wang HQ; Qian CH; Guo ZY; Li PM; Qiu ZJ
    World J Gastroenterol; 2022 Sep; 28(35):5141-5153. PubMed ID: 36188725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triptolide induces the expression of miR-142-3p: a negative regulator of heat shock protein 70 and pancreatic cancer cell proliferation.
    MacKenzie TN; Mujumdar N; Banerjee S; Sangwan V; Sarver A; Vickers S; Subramanian S; Saluja AK
    Mol Cancer Ther; 2013 Jul; 12(7):1266-75. PubMed ID: 23635652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies.
    Torres MP; Ponnusamy MP; Chakraborty S; Smith LM; Das S; Arafat HA; Batra SK
    Mol Cancer Ther; 2010 May; 9(5):1419-31. PubMed ID: 20423995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.
    Zhuo M; Yuan C; Han T; Cui J; Jiao F; Wang L
    BMC Cancer; 2018 Oct; 18(1):1032. PubMed ID: 30352575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342-3p.
    Zhu D; Zheng S; Fang C; Guo X; Han D; Tang M; Fu H; Jiang M; Xie N; Nie Y; Yao X; Chen Y
    Cancer Lett; 2020 May; 477():107-121. PubMed ID: 32120026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma.
    Hu J; Li L; Chen H; Zhang G; Liu H; Kong R; Chen H; Wang Y; Li Y; Tian F; Lv X; Li G; Sun B
    Cell Death Dis; 2018 Jul; 9(8):807. PubMed ID: 30042387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay of miR-21 and FoxO1 modulates growth of pancreatic ductal adenocarcinoma.
    Song W; Wang L; Wang L; Li Q
    Tumour Biol; 2015 Jun; 36(6):4741-5. PubMed ID: 25623117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs of the mir-17~92 cluster regulate multiple aspects of pancreatic tumor development and progression.
    Quattrochi B; Gulvady A; Driscoll DR; Sano M; Klimstra DS; Turner CE; Lewis BC
    Oncotarget; 2017 May; 8(22):35902-35918. PubMed ID: 28415794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-628-5p inhibits invasion and migration of human pancreatic ductal adenocarcinoma via suppression of the AKT/NF-kappa B pathway.
    Zhou L; Jiao X; Peng X; Yao X; Liu L; Zhang L
    J Cell Physiol; 2020 Nov; 235(11):8141-8154. PubMed ID: 31957029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma.
    Gautam SK; Kumar S; Cannon A; Hall B; Bhatia R; Nasser MW; Mahapatra S; Batra SK; Jain M
    Expert Opin Ther Targets; 2017 Jul; 21(7):657-669. PubMed ID: 28460571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.
    du Rieu MC; Torrisani J; Selves J; Al Saati T; Souque A; Dufresne M; Tsongalis GJ; Suriawinata AA; Carrère N; Buscail L; Cordelier P
    Clin Chem; 2010 Apr; 56(4):603-12. PubMed ID: 20093556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
    Zhao WG; Yu SN; Lu ZH; Ma YH; Gu YM; Chen J
    Carcinogenesis; 2010 Oct; 31(10):1726-33. PubMed ID: 20675343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
    Zeng B; Shi W; Tan G
    BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MUC4-promoted neural invasion is mediated by the axon guidance factor Netrin-1 in PDAC.
    Wang L; Zhi X; Zhu Y; Zhang Q; Wang W; Li Z; Tang J; Wang J; Wei S; Li B; Zhou J; Jiang J; Yang L; Xu H; Xu Z
    Oncotarget; 2015 Oct; 6(32):33805-22. PubMed ID: 26393880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival.
    Deng J; He M; Chen L; Chen C; Zheng J; Cai Z
    PLoS One; 2013; 8(10):e76450. PubMed ID: 24116110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer.
    Seshacharyulu P; Ponnusamy MP; Rachagani S; Lakshmanan I; Haridas D; Yan Y; Ganti AK; Batra SK
    Oncotarget; 2015 Mar; 6(7):5164-81. PubMed ID: 25686822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.